Infected episiotomy/laceration (superficial perineal wound infection) № of participants: 3420 (1 RCT) · Women undergoing operative vaginal delivery
Any antibiotics leads to lower infected episiotomy/laceration (superficial perineal wound… compared with placebo or no treatment (high certainty).
1 finding from 1 review
RR 0.53 [0.4, 0.69]
Studies not reported
High
Infected episiotomy/laceration (deep perineal wound infection № of participants: 3420 (1 RCT) · Women undergoing operative vaginal delivery
Any antibiotics leads to lower infected episiotomy/laceration (deep perineal wound infection № of… compared with placebo or no treatment (high certainty).
1 finding from 1 review
RR 0.46 [0.31, 0.69]
Studies not reported
High
Infected episiotomy/laceration (organ or space infection) № of participants: 3420 (1 RCT) · Women undergoing operative vaginal delivery
Any antibiotics showed no clear difference in infected episiotomy/laceration (organ or space infection) № of… compared with placebo or no treatment (low certainty).
1 finding from 1 review
RR 0.11 [0.01, 2.05]
Studies not reported
Low
Infected episiotomy/laceration (wound breakdown) № of participants: 2593 (1 RCT) · Women undergoing operative vaginal delivery
Any antibiotics probably leads to lower infected episiotomy/laceration (wound breakdown) № of participants:… compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
RR 0.52 [0.43, 0.63]
Studies not reported
Moderate
Endometritis · Women undergoing operative vaginal delivery
Any antibiotics showed no clear difference in endometritis № of participants: 3813 (2 RCTs) compared with placebo or no treatment (low certainty).
1 finding from 1 review
RR 0.32 [0.04, 2.64]
Studies not reported
Low
Urinary tract infection ‐ not measured · Women undergoing operative vaginal delivery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious infectious complications · Women undergoing operative vaginal delivery
Any antibiotics leads to lower serious infectious complications № of participants: 3420 (1 RCT) compared with placebo or no treatment (high certainty).
1 finding from 1 review
RR 0.44 [0.22, 0.89]
Studies not reported
High
Maternal adverse reactions · Women undergoing operative vaginal delivery
Any antibiotics showed no clear difference in maternal adverse reactions № of participants: 2593 (1 RCT) compared with placebo or no treatment (low certainty).
1 finding from 1 review
RR 2 [0.18, 22.05]
Studies not reported
Low
Relief of pain · women who have given birth vaginally, requiring analgesia for after‐birth pains.
NSAID probably leads to higher adequate pain relief as reported by the woman (5 to 8 hours) compared with placebo (moderate certainty).
1 finding from 1 review
Maternal adverse events (6 to 8 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.
NSAID may leads to lower maternal adverse events (6 to 8 hours) compared with opioid (low certainty).
1 finding from 1 review
Neonatal adverse events · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any breastfeeding at hospital discharge · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any breastfeeding at 6 weeks postpartum · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of pain · women who have given birth vaginally, requiring analgesia for after‐birth pains.
Opioid showed no clear difference in adequate pain relief as reported by the woman (5 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review
Need for additional pain relief (6 to 8 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.
Opioid may leads to lower need for additional pain relief (6 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review
Maternal adverse events (6 to 8 hours) · women who have given birth vaginally, requiring analgesia for after‐birth pains.
Opioid showed no clear difference in maternal adverse events (6 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review
Neonatal adverse events · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · women who have given birth vaginally, requiring analgesia for after‐birth pains.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Additional pain relief · women who have given birth vaginally, requiring analgesia for after‐birth pains.
NSAID may leads to lower need for additional pain relief (5 to 8 hours) compared with placebo (low certainty).
1 finding from 1 review